Escitalopram and paroxetine in the treatment of generalised anxiety disorder
Authors:
- David S. BaldwinDBDavid S. Baldwin
- Anna Karina Trap HuusomAHAnna Karina Trap Huusom
- Eli MæhlumEMEli Mæhlum
- 1 September 2006
- journal article
- research article
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- Vol. 189 (3) , 264-272
Abstract
Background: It is uncertain whether higher doses of selective serotonin reuptake inhibitors have greater efficacy in generalised anxiety disorder.Aims: To assess the efficacy of different doses of escitalopram in generalised anxiety disorder.Method: Randomised, double-blind, placebo-controlled, fixed-dose, parallel-group, 12-week study, with 681 patients: placebo (n=139); escitalopram, 5 mg/day, (n=134); 10 mg/day (n=136); 20 mg/day (n=133); paroxetine, 20 mg/day (n=139).Results: Mean change in the primary efficacy measure was greater with escitalopram 10 and 20 mg than with placebo; 10 mg was more efficacious than paroxetine. Paroxetine was superior to placebo on some secondary measures, at sometime points. Compared with placebo, more patients withdrew because of adverse events with escitalopram 20 mg and paroxetine.Conclusions: Escitalopram was efficacious in generalised anxiety disorder, 20 was not significantly superior to 10 mg/day Escitalopram 10 mg was more efficacious than paroxetine.Keywords
This publication has 19 references indexed in Scilit:
- Sertraline Treatment for Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2006
- Treatment of generalized anxiety disorder with escitalopram: Pooled results from double-blind, placebo-controlled trialsJournal of Affective Disorders, 2005
- Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose studyDepression and Anxiety, 2004
- Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose studyDepression and Anxiety, 2004
- Paroxetine Treatment of Generalized Anxiety Disorder: A Double-Blind, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2003
- ECNP Consensus Meeting March 2000European Neuropsychopharmacology, 2002
- Paroxetine in the Treatment of Generalized Anxiety DisorderThe Journal of Clinical Psychiatry, 2001
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959